JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Others

A1267 Adapalene

Target: RARs

Summary: RARβ and RARγ agonist

insoluble in H2O; insoluble in EtOH; ≥10.31 mg/mL
A8327 Verteporfin

Target: YAP

Summary: Photosensitizer used in photodynamic therapy

insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL
A8506 Potassium Canrenoate

Target: Aldosterone receptor

Summary: Aldosterone antagonist

insoluble in EtOH; insoluble in DMSO; ≥117.4 mg/mL
A8534 Terfenadine

Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels

Summary: Histamine H1-receptor antagonist

insoluble in H2O; ≥18 mg/mL
A8537 Thioridazine HCl

Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors

Summary: Calcium channel protein inhibitor
A8397 Chlorothiazide

Target: Carbonic Anhydrases

Summary: Carbonic anhydrase inhibitor

insoluble in H2O; insoluble in EtOH; ≥14.85 mg/mL
A8809 Vorapaxar

Target: Protease-Activated Receptors

Summary: PAR-1 antagonist,potent and orally active

≥24.65 mg/mL
A8814 NH125
1 Citation

Target: eEF-2

Summary: Selective eEF-2 kinase inhibitor

≥25.9 mg/mL
B3021 Atglistatin

Target: ATGL

Summary: ATGL inhibitor, potent and selective

insoluble in H2O; insoluble in EtOH; ≥14.15 mg/mL
B3179 PTC-209

Target: BMI-1

Summary: Bmi-1 inhibitor,cell-permeable and small-molecule

≥24.75 mg/mL